Citadel Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Citadel Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$43K	–	14402
2025 Q1	$43K	Buy	+500	New	+$41K	﹤0.01%	12466
2024 Q3	–	Sell	-700	Closed	-$48.2K	–	14959
2024 Q2	$48.2K	Buy	700 +600	+600%	+$40.6K	﹤0.01%	11800
2024 Q1	$7.26K	Sell	100 -1,200	-92%	-$80.2K	﹤0.01%	13624
2023 Q4	$79.6K	Hold	1,300	–	–	﹤0.01%	11231
2023 Q3	$74.3K	Hold	1,300	–	–	﹤0.01%	11256
2023 Q2	$77.3K	Buy	1,300 +1,200	+1,200%	+$71.8K	﹤0.01%	11283
2023 Q1	$6.26K	Buy	+100	New	+$6.24K	﹤0.01%	13820
2021 Q3	–	Sell	-16,700	Closed	-$870K	–	14428
2021 Q2	$870K	Sell	16,700 -600	-3%	-$28.8K	﹤0.01%	8714
2021 Q1	$763K	Sell	17,300 -1,000	-5%	-$42K	﹤0.01%	8757
2020 Q4	$638K	Buy	+18,300	New	+$650K	﹤0.01%	7688
2018 Q4	–	Sell	-20,600	Closed	-$781K	–	9595
2018 Q3	$781K	Buy	20,600 +12,200	+145%	+$461K	﹤0.01%	5960
2018 Q2	$322K	Buy	+8,400	New	+$283K	﹤0.01%	7093

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's PBH Position: Q1 2026 in Review

Citadel Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 25% in Q1 2026, selling an estimated $3.91M and leaving 183,440 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Citadel Advisors first reported a position in PBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $15M in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

Citadel Advisors held 183,440 shares of Prestige Consumer Healthcare worth $10.9M as of Q1 2026.
Citadel Advisors sold 60,221 Prestige Consumer Healthcare shares in Q1 2026, an estimated $3.91M.
Prestige Consumer Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3136 holding.
Citadel Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 46 quarters since.
Citadel Advisors's Prestige Consumer Healthcare position peaked at $15M in Q4 2025.
355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.